Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8140861rdf:typepubmed:Citationlld:pubmed
pubmed-article:8140861lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:8140861lifeskim:mentionsumls-concept:C0349632lld:lifeskim
pubmed-article:8140861lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:8140861lifeskim:mentionsumls-concept:C0026068lld:lifeskim
pubmed-article:8140861pubmed:issue4lld:pubmed
pubmed-article:8140861pubmed:dateCreated1994-4-28lld:pubmed
pubmed-article:8140861pubmed:abstractTextTwo cases of splenic lymphoma with villous lymphocytes (SLVL) were diagnosed on the basis of marked splenomegaly, circulating villous lymphocytes, serum IgM monoclonal paraprotein and bone marrow infiltration. Immunological studies confirmed the B cell phenotype (CD19+, CD20+, CD22+ and CD5- and CD25-). Ultrastructural studies revealed characteristic uneven villi with polar predisposition. Interferon-alpha therapy in 1 patient did not result in any clinical or hematological improvement. This is the first report of SLVL from the Middle East.lld:pubmed
pubmed-article:8140861pubmed:languageenglld:pubmed
pubmed-article:8140861pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8140861pubmed:citationSubsetIMlld:pubmed
pubmed-article:8140861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8140861pubmed:statusMEDLINElld:pubmed
pubmed-article:8140861pubmed:issn0001-5792lld:pubmed
pubmed-article:8140861pubmed:authorpubmed-author:DhabharB NBNlld:pubmed
pubmed-article:8140861pubmed:authorpubmed-author:PanditaRRlld:pubmed
pubmed-article:8140861pubmed:authorpubmed-author:al-BaharSSlld:pubmed
pubmed-article:8140861pubmed:authorpubmed-author:al-BaharEElld:pubmed
pubmed-article:8140861pubmed:issnTypePrintlld:pubmed
pubmed-article:8140861pubmed:volume90lld:pubmed
pubmed-article:8140861pubmed:ownerNLMlld:pubmed
pubmed-article:8140861pubmed:authorsCompleteYlld:pubmed
pubmed-article:8140861pubmed:pagination198-201lld:pubmed
pubmed-article:8140861pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:meshHeadingpubmed-meshheading:8140861-...lld:pubmed
pubmed-article:8140861pubmed:year1993lld:pubmed
pubmed-article:8140861pubmed:articleTitleSplenic lymphoma with villous lymphocytes. Report of first 2 cases from the Middle East.lld:pubmed
pubmed-article:8140861pubmed:affiliationDepartment of Haematology, Kuwait Cancer Control Centre.lld:pubmed
pubmed-article:8140861pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8140861pubmed:publicationTypeReviewlld:pubmed
pubmed-article:8140861pubmed:publicationTypeCase Reportslld:pubmed